Class Central is learner-supported. When you buy through links on our site, we may earn an affiliate commission.

Brown University

Low Threshold Buprenorphine

Brown University via Independent

This course may be unavailable.

Overview

Program Release: October 22, 2020 Expiration Date: October 22, 2022 Estimated time to complete: 30 Minutes There are no prerequisites for participation. Guest Speaker Era Kryzhanovskaya, MD Assistant Professor, Medicine University of California, San Francisco School of Medicine Chair, Controlled Substance Review Committee UCSF Health | San Francisco, CA Program Description This module will review the principles and steps in starting a patient on buprenorphine same day as the visit. Method of Participation and How to Receive CME Credit There are no fees for participating in and receiving credit for this activity. Review the activity objectives, faculty information, and CME information prior to participating in the activity. View the CME presentations Complete the CME activity evaluation at the conclusion of the activity in order to receive a credit certificate. Faculty Disclosure In accordance with the disclosure policy of the Brown University CME Office as well as standards set forth by the Accreditation Council on Continuing Medical Education (ACCME), speakers have been asked to disclose any relevant financial relationship with the manufacturers of any commercial products and/or provider of commercial services discussed in any educational presentation and with any commercial supporters or exhibitors of this activity. The intent of this policy is not to prevent a speaker with a potential conflict of interest from making a presentation but to identified openly so that the listener may form his/her own opinion. Any potential conflicts of interest have been resolved prior to this presentation. This activity may include discussion of off-label or investigative drugs uses. Speakers are aware that it is their responsibility to disclose to the audience this information. Individual Faculty Disclosure information may be found in the conference handouts. Faculty Disclosure/Conflict of Interest The following speaker and planning committee members have disclosed that they have no relevant financial relationships: Speaker: Era Kryzhanovskaya, MD Planning Committee Members: Rahul Vanjani, MD, MSc, Maria Sullivan Disclaimer and Privacy Policy Privacy Policy: The Office of Continuing Medical Education (CME) and its educational partners protect the privacy of personal and other information regarding participants and educational collaborators. The CME Office maintains its Internet site as an information resource and service for physicians, other health professionals, and the public. The CME Office will keep your personal information confidential when you participate in a CME Internet-based program. CME collects only the information necessary to provide you with the services that you request. Disclaimer: This educational program is designed to present scientific information and opinion to Health professionals, to stimulate thought, and further investigation.

Syllabus

At the conclusion of this session, attendees should be able to:

  1. Define low threshold buprenorphine initiation
  2. Describe the rationale for low threshold buprenorphine
  3. List three components of the initiation process 

Reviews

Start your review of Low Threshold Buprenorphine

Never Stop Learning.

Get personalized course recommendations, track subjects and courses with reminders, and more.

Someone learning on their laptop while sitting on the floor.